Antibody Engineering & Therapeutics Europe – Pioneering the Future of Antibody-Based Medicines is Europe’s foremost conference and exhibition dedicated to next-generation therapeutic antibodies. Serving as the European counterpart to the prestigious U.S.-based Antibody Engineering & Therapeutics, the event brings together leading scientists, clinicians, and industry professionals to explore the latest advances in antibody research, development, and clinical application. Organized annually by Informa Connect, a division of Informa PLC known for delivering high-level knowledge-driven events, the conference rotates among Europe’s premier centers of scientific research and innovation, providing participants with an ideal environment for networking, collaboration, and insight into cutting-edge therapeutic solutions.
Driving innovation across the antibody value chain
The program is designed to address the entire spectrum of antibody therapeutics, from early discovery to clinical translation and commercial implementation. Attendees gain access to a wealth of specialized topics, including:
Discovery of novel targets and innovative selection techniques
Advanced binding formats, bispecific and multispecific antibodies, and non-IgG constructs
Antibody-drug conjugates (ADCs) and novel payload strategies
AI and machine learning applications for therapeutic design and optimization
This comprehensive focus ensures that participants can explore both the scientific foundations and practical applications of next-generation antibody therapies, gaining insights into emerging trends that are shaping the biopharmaceutical landscape.
Translating research into clinical impact
A central objective of Antibody Engineering & Therapeutics Europe is bridging the gap between preclinical research and clinical implementation. The conference emphasizes strategies for:
Translating laboratory discoveries into therapeutic candidates
Manufacturing and formulation of complex biological agents
Exploring therapeutic opportunities beyond oncology, including immunology, neurology, and autoimmune diseases
By highlighting these translational processes, the event supports professionals in navigating the challenges of moving innovative antibody candidates from bench to bedside, ensuring that scientific breakthroughs have real-world impact.
Cutting-edge technologies and methodologies
The conference also serves as a platform for showcasing state-of-the-art technologies that drive innovation in antibody therapeutics. Topics and presentations often cover:
High-throughput screening and selection platforms
Computational modeling and AI-driven optimization of antibody candidates
Advanced bioanalytical techniques and characterization methods
Novel delivery systems and formulation strategies for enhanced efficacy
Regulatory considerations and best practices in clinical development
These sessions provide attendees with actionable knowledge that can improve research efficiency, accelerate drug development timelines, and optimize therapeutic outcomes.
Networking and interdisciplinary collaboration
Antibody Engineering & Therapeutics Europe thrives on its ability to bring together experts from diverse sectors, including academia, biotechnology, pharmaceutical companies, and regulatory agencies. The conference offers multiple avenues for professional interaction: panel discussions, roundtables, poster sessions, and dedicated networking events. These opportunities foster collaborations that span discovery, development, and commercialization, helping to translate scientific innovation into tangible therapeutic solutions.
Shaping the future of biopharmaceutical innovation
Ultimately, the conference is more than a meeting it is a strategic hub for knowledge exchange, professional growth, and industry advancement. Participants leave with:
Insights into cutting-edge antibody research and development
Exposure to novel technologies and AI-driven methodologies
Connections with leading experts and potential collaborators
Practical guidance for translating scientific discoveries into clinical therapies
By covering the full spectrum of antibody engineering, therapeutic development, and clinical translation, Antibody Engineering & Therapeutics Europe plays an indispensable role in shaping the next generation of biopharmaceutical innovation in Europe and beyond. It is a must-attend event for anyone involved in the discovery, development, and application of antibody-based therapies.
